Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FDA Safety Plan Is Only First Step, But Agency Says No New Authority Needed

This article was originally published in The Tan Sheet

Executive Summary

FDA's description of its plan to improve oversight of drug safety acknowledges the agency's efforts are part of an ongoing process - but not necessarily one needing outside involvement

You may also be interested in...



FDA Risk Communication Panel’s Charter Is Tweaked As Members Are Named

FDA is modifying the charter for its Risk Communication Advisory Committee to reflect new powers the agency gained as part of the passed FDA reauthorization bill

FDA Risk Communication Panel’s Charter Is Tweaked As Members Are Named

FDA is modifying the charter for its Risk Communication Advisory Committee to reflect new powers the agency gained as part of the passed FDA reauthorization bill

FDA Risk Communication Panel’s Charter Is Tweaked As Members Are Named

FDA is modifying the charter for its Risk Communication Advisory Committee to reflect new powers the agency gained as part of the passed FDA reauthorization bill

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100182

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel